[This review was originally posted at the Nieman Journalism Lab Tramadol Dosage, on June 18, 2010.]

The FTC's last round of input: The U.S. Federal Trade Commission wrapped up its series of forums on journalism and public policy Tuesday, and this forum got quite a bit more attention than the others — partly because it's the last one, and partly because the FTC released its draft of possible policy proposals a few weeks ago, which gave people something concrete to pick apart.

Before the forum, Tramadol use, The New York Times' Jeremy Peters and TBD's Steve Buttry both gave good summaries of what various people are saying about the issue, and Save the News' Fiona Morgan gave a helpful, detailed description of what went on at the forum itself. As for the FTC's final report due out this fall, Poynter's Rick Edmonds and Bloomberg Businessweek's Olga Kharif both wrote that we're unlikely to see any proposals for significant government intervention in the news business. Edmonds offers a handful of reasons that the idea has fallen out of favor: Newspapers' financial fortunes have improved lately, we've seen an explosion of strongly backed digital journalism experiments, Tramadol wiki, the government might not be able to do it well, and news organizations themselves aren't sure what they want from Uncle Sam. Both Edmonds and Kharif also noted that Congress won't be willing to be seen as bailing out another for-profit industry.

A few more voices — media economics professor Robert Picard, TBD's Mandy Jenkins and conservative Denver Post columnist David Harsanyi — joined the anti-subsidy chorus this week, and the Times' Eric Pfanner provided some evidence to back them up, pointing out that countries with the largest direct subsidies for newspapers also have the lowest newspaper readership, Tramadol Dosage. (He also noted the U.S. media's extreme reliance on advertising compared with the rest of the world.)

Other folks offered a few ideas of what policy proposals they'd like to see the FTC endorse. Edmonds wants to see nonprofits allowed to accept advertising, Buy Tramadol from mexico, j-prof C.W. Anderson says public policy has a role in "fostering an entrepreneurial, innovative, reinvented journalistic sphere," Salon's Dan Gillmor stumps for open broadband subsidies, and Save the News' Josh Stearns lists five ideas he wants endorsed. Tramadol Dosage, The themes that run across several of those people's proposals are clear: Net neutrality, expanded broadband, open government data, and encouragement for innovation, rather than protection for traditional media businesses.

—

Google News goes human: One low-key but potentially significant development from late last week: As the Lab's Megan Garber reported, after Tramadol, Google News began an experiment called Editors' Picks, in which editors from partner news organizations like the BBC and the Washington Post curate lists of news articles to go along with Google's algorithm-run selections. Garber notes what a shift this is from Google's historical approach to news aggregation and ties it to the quest for serendipity: "This is one way of replicating the offline experience of serendipity-via-bundling within the sometimes scattered experience of online news consumption," she says.

GigaOM's Mathew Ingram saw in the project a similar sign of a shift toward human-powered news aggregation at Google, No prescription Tramadol online, though he noted that Google has tried numerous news-related experiments that never caught on. That's exactly what a Google spokesperson told paidContent's Staci Kramer, and both sites mentioned Google's ill-fated commenting experiment as an example.

Still, Mashable's Vadim Lavrusik loved this idea, making a case for the value of human editors in making sure that people are reading what they need to know online as well as what they want to know, Tramadol Dosage. In other Google News news, its creator, Krishna Bharat, gave a long interview in which he discussed its role in journalism and his idea of what the future of journalism might look like, buy Tramadol without prescription.

—

Murdoch picks up some paid-content pieces: Rupert Murdoch's News Corp. continued its long, steady march toward a paid-news future with a few small but potentially important moves this week: It bought the Skiff mobile software platform from the newspaper chain Hearst — not the Skiff e-reader itself, though it seems they're working on that — invested in Journalism Online, Steve Brill's news paid-content venture, and bid to take full control of British Sky Broadcasting, Europe's largest for-pay broadcaster.

Hollywood Reporter's Andrew Wallenstein called the first two moves huge news for the digital news business, arguing that Murdoch is setting the standard for the way everyone else does business online. "This is about laying the groundwork for the very process by which people pay for that news; namely, the device they consume it on and the virtual storefront that handles the payment, is Tramadol safe," he wrote. Tramadol Dosage, And with BSkyB's digital music and broadband services, it looks like Murdoch's hoping to add another major asset in his plans to find new ways to get people to pay for not only news, but digital entertainment media as well.

—

A theory of the political press defined: If you've been following NYU professor Jay Rosen on Twitter or reading his blog for any length of time, you've probably absorbed a general sense of his guiding philosophy about the American political press. But this week he posted the definitive explanation of that philosophy, which is most simply that political journalists' prevailing ideology is one of false equivalency between two sides of political extremists, Tramadol no prescription, while they (and their favorite politicians) stand at the sane, savvy, skeptical center. It's obviously just one critic's opinion, but it's a remarkably helpful frame to help interpret what the Washington press corps values and why it does what it does.

There's some fascinating discussion about Rosen's ideas in the lengthy comments of his post, and he got a few thoughtful responses elsewhere, as well, Tramadol no rx. The Atlantic's Conor Friedersdorf agreed with the main thrust of Rosen's argument, though he challenged the assertion that political journalists are "big believers in the law of unintended consequences" who don't pay much attention to the direct consequences of public policy. The Economist likewise endorses the post but counters that Rosen's concepts of "he said, she said journalism" and "the sphere of deviance" are at odds, Tramadol Dosage. Over at Slate, Tom Scocca affirms a point of Rosen's about journalists' disregard for street protests, and Australian journalist Jonathan Holmes adapted the concept to the Australian media. Doses Tramadol work, Also, the Atlantic's Marc Ambinder — as a political editor, part of the tribe Rosen was dissecting — asked the professor what he would have the political press think instead. Rosen has promised an answer.

—

Future-of-news thoughts and innovation: Before we get to the reading roundup, a note on a couple of interesting items that the Lab has been highlighting this week. Tramadol Dosage, First, our sister publication, Nieman Reports, has published its quarterly issue, which is always chock-full of thought-provoking essays on journalism in transition. This summer's issue is titled "What's Next for News?" so it's right along the lines of the stuff we write about here at the Lab, where can i order Tramadol without prescription. The Lab has been pointing out several of the issue's 36 pieces — including thoughts on the Internet's effects on our thinking, the editor-as-gatekeeper role, and the semantic web — but there's plenty more out there, so go look around.

Second, Buy cheap Tramadol no rx, the Knight News Challenge announced the 12 winners of its $2.74 million worth of grants for innovative journalism projects. The Lab's Josh Benton has a rundown of the winners and a few observations about the crop as a whole, and we've got profiles of a few of the initiatives, too. There's Stroome, the wiki-style collaborative video-editing site; Public Radio Exchange, a crowdfunding project for public radio journalism; and Order in the Court 2.0, an effort to open up courtrooms through new media, Tramadol Dosage. They should have several more profiles up over the next few days (probably even before this post is published) if you're in the mood to be encouraged by innovation in news.

—

Reading roundup: Two ongoing discussions, one news economics development, Tramadol gel, ointment, cream, pill, spray, continuous-release, extended-release, and one thoughtful piece on context:

— Two news economics experts, Alan Mutter and Frederic Filloux, weighed in this week with their assessments of iPad news apps so far. Mutter looks at the winners and losers, and Filloux talks about what makes iPad news apps work. Online buying Tramadol, — We've been hearing for a couple of weeks about what the Internet is (or isn't) doing to our brains, and that conversation continued with a defense of the web by The New York Times' Nick Bilton a caution to doomsayers by psychology professor Steven Pinker.

— Consulting firm PricewaterhouseCoopers estimated this week that Internet ad revenue will surpass newspaper ad revenue by 2014. Both will still remain behind TV ad revenue, they said.)

— Finally, former journalist John Zhu wrote a wonderful explanation of the state of, well, explanation in the news. (Complete with helpful visual aids!) If you're interested at all in how journalists can make complex stories more understandable to people, this is the perfect place to start putting together where we've been and where we could be going.

Similar posts: Diflucan Cost. Diflucan For Sale. Armour Price. Cipro alternatives. Armour blogs. Diflucan duration.
Trackbacks from: Tramadol Dosage. Tramadol Dosage. Tramadol Dosage. Tramadol class. Tramadol pics. Tramadol trusted pharmacy reviews.

[This review was originally posted at the Nieman Journalism Lab Lipitor Dosage, on April 16, 2010.]

Schmidt and Huffington’s advice for news execs: This week wasn’t a terribly eventful one in the future-of-journalism world, but a decent amount of the interesting stuff that was said came out of Washington D.C., site of the annual American Society of News Editors conference. The most talked-about session there was Sunday night’s keynote address by Google CEO Eric Schmidt, who told the news execs there that their industry is in trouble because it hasn’t found a way to sustain itself financially, not because its way of producing or delivering news is broken. “We have a business-model problem, My Lipitor experience, we don’t have a news problem,” Schmidt said.

After buttering the crowd up a bit, Schmidt urged them to produce news for an environment that’s driven largely by mobile devices, immediacy, and personalization, and he gave them a glimpse of what those priorities look like at Google. Politico and the Lab’s Megan Garber have summaries of the talk, Lipitor canada, mexico, india, and paidContent has video.

There were bunches more sessions and panels (American Journalism Review’s Rem Rieder really liked them), but two I want to highlight in particular. One was a panel with New York Times media critic David Carr, new-media titan Ariana Huffington and the Orlando Sentinel’s Mark Russell on the “24/7 news cycle.” The Lab’s report on the session focused on four themes, Lipitor dangers, with one emerging most prominently — the need for context to make sense out of the modern stream of news. St. Petersburg Times media critic Eric Deggans and University of Maryland student Adam Kerlin also zeroed in on the panelists’ call to develop deeper trust and participation among readers.

The second was a presentation by Allbritton’s Steve Buttry that provides a perfect fleshing-out of the mobile-centric vision Schmidt gave in his keynote, Lipitor Dosage. Poynter’s Damon Kiesow had a short preview, and Buttry has a longer one that includes a good list of practical suggestions for newsrooms to start a mobile transformation. (He also has slides from his talk, and he posted a comprehensive mobile strategy for news orgs back in November, buy Lipitor no prescription, if you want to dive in deep.)

There was plenty of other food for thought, too: Joel Kramer of the Twin Cities nonprofit news org MinnPost shared his experiences with building community, and one “where do we go from here?” panel seemed to capture news execs’ ambivalence about the future of their industry. Students from local universities also put together a blog on the conference with a Twitter stream and short recaps of just about every session, Lipitor brand name, and it’s worth a look-through. Two panels of particular interest: One on government subsidies for news and another with Kelly McBride of Poynter’s thoughts on the “fifth estate” of citizen journalists, bloggers, nonprofits and others.

—

Is a closed iPad bad for news?: In the second week after the iPad’s release, much of the commentary centered once again on Apple’s control over the device. Lipitor Dosage, In a long, thoughtful post, Media watcher Dan Gillmor focused on Apple’s close relationship with The New York Times, posing a couple of arresting questions for news orgs creating iPad apps: Does Apple have the unilateral right to remove your app for any reason it wants, and why are you OK with that kind of control?

On Thursday he got a perfect example, when the Lab’s Laura McGann reported that Pulitzer-winning cartoonist Mark Fiore’s iPhone app was rejected in December because it “contains content that ridicules public figures.” Several other folks echoed Gillmor’s alarm, with pomo blogger Terry Heaton asserting that the iPad is a move by the status quo to retake what it believes is its rightful place in the culture. O’Reilly Radar’s Jim Stogdill says that if you bought an iPad, Lipitor pictures, you aren’t really getting a computer so much as “a 16GB Walmart store shelf that fits on your lap … and Apple got you to pay for the building.” And blogging/RSS/podcasting pioneer Dave Winer says the iPad doesn’t change much for news because it’s so difficult to create media with.

But in a column for The New York Times, web thinker Steven Johnson adds an important caveat: While he’s long been an advocate of open systems, he notes that the iPhone software platform has been the most innovative in the history in computing, despite being closed. Lipitor reviews, He attributes that to simpler use for its consumers, as well as simpler tasks for developers. While Johnson still has serious misgivings about the Apple’s closed policy from a control standpoint, he concludes that “sometimes, if you get the conditions right, a walled garden can turn into a rain forest.”

In related iPad issues, Lipitor price, coupon, DigitalBeat’s Subrahmanyam KVJ takes a step back and looks at control issues with Apple, Facebook, Twitter and Google. Florida j-prof Mindy McAdams has a detailed examination of the future of HTML5 and Flash in light of Adobe’s battle with Adobe over the iPad. Oh yeah, and to the surprise of no one, a bunch of companies, including Google, are developing iPad competitors.

—

News editors’ pessimism: A survey released Monday by the Pew Research Center’s Project for Excellence in Journalism presented a striking glimpse into the minds of America’s news executives, Lipitor Dosage. Lipitor dosage, Perhaps most arresting (and depressing) was the finding that nearly half of the editors surveyed said that without a significant new revenue stream, their news orgs would go under within a decade, and nearly a third gave their org five years or less.

While some editors are looking at putting up paywalls online as that new revenue source, the nation’s news execs aren’t exactly overwhelmed at that prospect: 10 percent are actively working on building paywalls, and 32 percent are considering it. Much higher percentages of execs are working on online advertising, cheap Lipitor, non-news products, local search and niche products as revenue sources.

One form of revenue that most news heads are definitely not crazy about is government subsidy: Three quarters of them, including nearly 90 percent of newspaper editors, had “serious reservations” about that kind of funding (the highest level of concern they could choose). Effects of Lipitor, The numbers were lower for tax subsidies, but even then, only 19 percent said they’d be open to it.

The report itself makes for a pretty fascinating read, and The New York Times has a good summary, too. The St, Lipitor blogs. Pete Times’ Eric Deggans wonders Lipitor Dosage, how bad things would have to get before execs would be willing to accept government subsidies (pretty bad), and the Knight Digital Media Center’s Amy Gahran highlights the statistics on editors’ thoughts on what went wrong in their industry.

—

Twitter rolls out paid search: This week was a big one for Twitter: We finally found out some of the key stats about the microblogging service, including how many users it has (105,779,710), and the U.S. Library of Congress announced it’s archiving all of everyone’s tweets, ever.

But the biggest news was Twitter’s announcement that it will implement what it calls Promoted Tweets — its first major step toward its long-anticipated sustainable revenue plan. As The New York Times explains, Promoted Tweets are paid advertisements that will show up first when you search on Twitter and, Lipitor samples, down the road, as part of your regular stream if they’re contextually relevant. Or, in Search Engine Land’s words, it’s paid search, at least initially.

Search blogger John Battelle has some initial thoughts on the move: He thinks Twitter seems to be going about things the right way, buy no prescription Lipitor online, but the key shift is that this “will mark the first time, ever, that users of the service will see a tweet from someone they have not explicitly decided to follow.” Alex Wilhelm of The Next Web gives us a helpful roadmap of where Twitter’s heading with all of its developments.

—

Anonymity and comments: A quick addendum to last month’s discussion about anonymous comments on news sites (which really has been ongoing since then, just very slowly): The New York Times’ Richard Perez-Pena wrote about many news organizations’ debates over whether to allow anonymous comments, Lipitor class, and The Guardian’s Nigel Willmott explained why his paper’s site will still include anonymous commenting.

Meanwhile, former Salon-er Scott Rosenberg told media companies that they’d better treat it like a valuable conversation if they want it to be one (that means managing and directing it), rather than wondering what the heck’s the problem with those crazy commenters. And here at The Lab, Joshua Benton found that when the blogging empire Gawker made its comments a tiered system, their quality and quantity improved.

—

Reading roundup: This week I have three handy resources, three ideas worth pondering, and one final thought.

Three resources: If you’re looking for a zoomed-out perspective on the last year or two in journalism in transition, Daniel Bachhuber’s “canonical” reading list is a fine place to start. PaidContent has a nifty list of local newspapers that charge for news online, and Twitter went public with Twitter Media, a new blog to help media folks use Twitter to its fullest.

Three ideas worth pondering: Scott Lewis of the nonprofit news org Voice of San Diego talks to the Lab about how “explainers” for concepts and big news stories could be part of their business model, analysts Frederic Filloux and Alan Mutter take a close look at online news audiences and advertising, and Journal Register Co, Lipitor Dosage. head John Paton details his company’s plan to have one newspaper produce one day’s paper with only free web tools. (Jeff Jarvis, an adviser, shows how it might work and why he’s excited.)

One final thought: British j-prof Paul Bradshaw decries the “zero-sum game”attitude by professional journalists toward user-generated content that views any gain for UGC as a loss for the pros. He concludes with a wonderful piece of advice: “If you think the web is useless, make it useful. … Along the way, you might just find that there are hundreds of thousands of people doing exactly the same thing.”

Similar posts: Retin A No Rx. Flagyl No Rx. Armour For Sale. Purchase Cipro online no prescription. Synthroid class. Tramadol pharmacy.
Trackbacks from: Lipitor Dosage. Lipitor Dosage. Lipitor Dosage. Lipitor long term. Lipitor mg. Lipitor used for.